Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m6A RNA, FTO, ALKBH5 Expression in Type 2 Diabetic and Obesity Patients
Erhan Önalan, Burkay Yakar, Ebru Önalan Etem, et al.
Journal of College of Physicians And Surgeons Pakistan (2022) Vol. 32, Iss. 09, pp. 1143-1148
Open Access | Times Cited: 13

Showing 13 citing articles:

The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus
Daniel Benák, Stepanka Benakova, Lydie Plecitá‐Hlavatá, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 15
RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms
Miaochun Fang, Liwen Ye, Yue Zhu, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 157-157
Open Access
FTO-mediated Nrf2 demethylation alleviates high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells
Quan Cheng, Liqiong Zhou, Xinyu Fan, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
m6A demethylase ALKBH5 reduces ferroptosis in diabetic retinopathy through the m6A‐YTHDF1‐ACSL4 axis
Qinghui Liao, Yan Li, Meijing Cui, et al.
Diabetic Medicine (2025)
Closed Access
Changes in m6A in Steatotic Liver Disease
Belinda J. Petri, Matthew C. Cave, Carolyn M. Klinge
Genes (2023) Vol. 14, Iss. 8, pp. 1653-1653
Open Access | Times Cited: 10
m6A mRNA methylation: Biological features, mechanisms, and therapeutic potentials in type 2 diabetes mellitus
Yuanyuan Ren, Zi Li, Jiaoyu Li, et al.
Obesity Reviews (2023) Vol. 24, Iss. 12
Closed Access | Times Cited: 9
FTO in health and disease
Daniel Benák, Anna Ševčíková, Kristýna Holzerová, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Inhibition of inflammation and apoptosis through the cyclic GMP‐AMP synthase‐stimulator of interferon genes pathway by stress granules after ALKBH5 demethylase activation during diabetic myocardial ischaemia‐reperfusion injury
Wenyuan Li, Renwu Qin, Zhen Tang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3940-3957
Closed Access | Times Cited: 2
Investigação da conexão entre o gene associado a massa gorda e obesidade (FTO) com a predisposição ao Diabetes: revisão sistemática
Gabriel David da Silva Clemente, Rian Barreto Arrais Rodrigues de Morais, Leonardo Torres Camurça, et al.
Caderno Pedagógico (2024) Vol. 21, Iss. 8, pp. e7261-e7261
Open Access
FTO promotes gefitinib-resistance by enhancing PELI3 expression and autophagy in non-small cell lung cancer
Yuzheng He, Xiaoning Li, Haitao Li, et al.
Pulmonary Pharmacology & Therapeutics (2024) Vol. 87, pp. 102317-102317
Closed Access
Epigenetic inhibitors for cancer treatment
Hongchao Yuan, Yuanjun Lu, Yibin Feng, et al.
International review of cell and molecular biology (2023), pp. 89-144
Closed Access | Times Cited: 1
m6A epitranscriptomic modification in diabetic microvascular complications
Li-Chan Lin, Zhi-Yan Liu, Jingjing Yang, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 12, pp. 991-1008
Closed Access | Times Cited: 1
Page 1

Scroll to top